Is GeneFerm Biotechnology Co stock a buy?

Yes, GeneFerm Biotechnology Co pays dividends. Last time was Wednesday 31st of July 2024 where the investors holding the stock on Wednesday 10th of July 2024 were paid TWD2 per share. Over the last 7 times between 2017 and 2024, GeneFerm Biotechnology Co has paid TWD8.181891 with an average of TWD1.17 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for GeneFerm Biotechnology Co 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was TWD31.70, you would have made a profit of TWD17.35 per share or 54.73%

Yes, the average daily trading liquidity for GeneFerm Biotechnology Co is TWD24 166 thousand. You should therefore be able to get in and out of your positions relatively fast.

GeneFerm Biotechnology Co has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.13, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for GeneFerm Biotechnology Co to be medium [0.6 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.